RESUMO
OBJECTIVE: The aim: The aim of the study was to evaluate the effectiveness of osteotropic drugs in the treatment of destructive forms of apical periodontitis. PATIENTS AND METHODS: Materials and methods: The study was conducted at Danylo Halytsky Lviv National Medical University, Department of Therapeutic Dentistry, Lviv, Ukraine. As a result of the research, 185 patients with destructive forms of apical periodontitis (DFAP) were examined and treated. To characterize the effectiveness of treatment using criteria based on the provisions of the European Society of Endodontology. Thermometric studies of the oral mucosa were performed according to the method of L.Ye. Smolyanko and A.V. Lysovogo. RESULTS: Results: After 3 months, 145 treated patients (78.38%) out of the total number of subjects belonged to the 3rd category ("failure"). At the same time, this category included the largest share of patients of groups I and II of the study - 95.67% and 95.56%, respectively. In 70.21% of patients of group III, with transferred outside the apex PRP, and in 53.19% of persons of group IV, with the use of the composition «PRP + mp3 OsteoBiol¼ there were no clinical signs of DFAP. It was noted that 22 (46.81%) and 14 (29.79%) patients groups III and IV had no clinical signs of DFAP and radiologically determined a decrease in the focus of bone destruction of the periapical area, which allowed them to be classified as 2 - category of success - «incomplete recovery¼. CONCLUSION: Conclusions: The results of the research convincingly testify to the effectiveness of our proposed therapy for the treatment of dystrophic forms of apical periodontitis.
